SLC33A1 and Alzheimer disease: Finally, biochemical inhibition of ATase1 and ATase2, downstream of AT-1, can restore reticulophagy in AT-1 overexpressors, and genetic disruption of the Atases can rescue features of the AD-associated proteotoxicity8,9,11 (see also this study).